EIT Pharma

Private

Kirkland, WashingtonHealthcare & Life Scienceshttps://eitpharma.com/

Last Round

Series A

Aug 31, 2026

Total Funding Raised

$35M

Company Overview

EIT Pharma is a biotechnology company that develops therapies for infectious diseases, including treatments for chronic hepatitis D and acute respiratory infections.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologydrug developmentinfectious diseaseclinical trialshepatitis Dfarnesyltransferase inhibitorbiotech startuppeginterferon lambdalonafarnibrespiratory infectionclinical stagetherapeutic assetsdrug pipelinepharma R&D

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

EIT Pharma Comparables

Compare EIT Pharma with similar companies based on industry and business-model similarity.

EIT Pharma comparables — related companies by embedding similarity
Company	Similarity	Market Cap
Replicor Inc.	78%
Mirum Pharmaceuticals	77%
Gilead Sciences	73%

View all Comparables

EIT Pharma Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series A	Aug 31, 2026

View all Funding Rounds

EIT Pharma Investors

Notable investors and investment history

EIT Pharma investors
Investor	Rounds
Kayne Anderson Capital Advisors	Series A
Propel Bio Partners	Series A
Good Ventures	Series A

View all Investors

EIT Pharma Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

EIT Pharma Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about EIT Pharma's valuation, stock price, and market status.

Firmographic Details

HeadquartersKirkland, Washington

Employee Range6

Year Founded2025

Last FundingAug 31, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?